Multiple Sclerosis Society of Canada

Multiple Sclerosis Society of Canada

March 24, 2011 10:00 ET

endMS Research and Training Network Announces $500,000 Transitional Career Development Award Recipient

TORONTO, ONTARIO--(Marketwire - March 24, 2011) - The MS Society of Canada is proud to announce the recipient of the EMD Serono, Canada endMS Research and Training Network Transitional Career Development Award, Dr. Manu Rangachari of Harvard Medical School.

The award provides $500,000 to successful postdoctoral or clinical fellows to fund the last two years of their MS-focused fellowship and the first three years of their MS-focused faculty position in a Canadian institution.

Dr. Rangachari completed his Ph.D. at the University of Toronto. Currently residing in Boston, Massachusetts, he is a research fellow in the laboratory of Dr. Vijay Kuchroo at Brigham & Women's Hospital. His research is focused on the pathogenic role of T cells in a mouse model of MS.

"My goal is to become one of Canada's leaders in MS research. Thanks to the MS Society's endMS initiative, I will have the opportunity to continue my postdoctoral training at Harvard Medical School, where I am able to interact with some of the brightest minds in immunology and pathobiology," said Dr. Rangachari.

"Following my postdoctoral training, my endMS Transitional Career Development Award will provide generous support for the setup of an independent research programme in Canada that builds on my postdoctoral work, as well as on the wealth of MS research currently being pursued in Canada."

The award is supported by EMD Serono's gift of $500,000 to the endMS campaign, a $60 million initiative designed to attract, train and retain researchers in the field of MS, to accelerate the search for a cure.

"Creating an environment where research into MS will flourish in Canada is vital to increase our understanding of the disease, improve treatments and ultimately find a cure," says Deborah Brown, president of EMD Serono.

EMD Serono's generous support of the latest endMS Transitional Career Development Award is another step forward in its tremendous partnership with the MS Society that began well over a decade ago, and is continuing evidence of the common vision and goals that they share with the MS Society. EMD Serono's commitment to elevating awareness of MS and efforts to better understand it have helped make the MS Society the relied-upon resource for information and education on living well with MS.

"Attracting the best minds to the field of MS in Canada is essential to our mission of being a leader in finding a cure for this unpredictable disease," says Jon Temme, senior vice president of research and programs at the MS Society of Canada. "Congratulations to Dr. Rangachari for receiving this prestigious award and sincere gratitude to EMD Serono for the financial grant that makes it possible."

About the endMS Research and Training Network

The endMS Research and Network is funded by the MS Society's related MS Scientific Research Foundation and is the flagship investment of the $60 million endMS capital campaign. The endMS Network continues to make progress towards accomplishing its objectives of attracting, training, and retaining trainees and researchers who will commit their careers to further discovery in this field and expanding and enhancing opportunities to conduct MS research in Canada. To learn more about the endMS Research and Training Network, please visit: To donate, please visit

About multiple sclerosis and the Multiple Sclerosis Society of Canada

Multiple sclerosis is a chronic, often disabling disease of the brain and spinal cord. It is the most common neurological disease of young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives. The MS Society provides services to people with MS and their families and funds research to find the cause and cure for this disease. Please visit or call 1-800-268-7582 to make a donation or for more information.

Note: As with all funding from pharmaceutical companies – which accounts for only two percent of the MS Society's overall revenue – EMD Serono's contribution is subject to the MS Society's strict policies that prevent any control or influence by the donor on our decision-making. This is consistent with the ethical principles established by the association of Canada's research-based pharmaceutical companies which require that they assure the independence and integrity of stakeholders, in terms of their operations, policies and activities.

Contact Information

  • Multiple Sclerosis Society of Canada
    Stewart Wong
    Senior Manager, Communications and Media Relations